Our founder, our CMO, and our BizDev Lead are making their way to Cannes for the @EthCC gathering at the end of March. The team will be present in the city from March 30-Apr 2. Should you find yourself in the vicinity during those dates, we warmly invite you to reach out and say hello. We would be absolutely delighted to sit down over a coffee to discuss tokenized finance infra, explore the topic of vaults, and share insights regarding what people are building this year.
At its core, decentralized finance lending operates as a credit marketplace situated on the blockchain. For a comprehensive look at how these mechanisms work and how they mirror TradFi, take a look at the analysis provided by @letsgetonchain.
We are pleased to introduce a new capability within the Onyx platform. Managers are now able to configure a hard hurdle rate specifically for performance fees. For further information on this update, please visit: https://docs.enzyme.finance/onyx-user-documentation/enzyme-vault/fees/hurdle-rate?utm_source=linkedin&utm_medium=organic&utm_content=post
Automated rebalancing has officially become a plug-and-play component for an Onyx strategy. Special recognition goes to @31ThirdProtocol for launching this automation for Safe-controlled structures using @Safe modules, which is now live on @buildonbase. You can simply set target weights, rebalance baskets, and execute in one go, all without the need for custom development. See the process below 👇
Tokenized finance cannot rely on a standard approach because every issuer utilizes a unique infrastructure. To address this need for flexibility, Enzyme empowers partners to design vaults tailored to specific assets and chains, including hybrid configurations, while ensuring you retain authority where it counts. Connect with our team today at https://enzyme.finance/contact-us?utm_source=x&utm_medium=organic&utm_content=post
We have recently observed an increase in fraudulent profiles mimicking Enzyme and attempting to contact members of our community. Please be advised that this handle represents the one and only official Enzyme account. We strongly recommend that you ignore any suspicious communications or replies claiming to represent us, and strictly avoid clicking on any unidentified links. It is essential to verify the username thoroughly. We appreciate your cooperation in flagging these impostors and keeping the ecosystem secure 🤝
It is encouraging to see the @Ethereum Foundation establish a solid foundation for the future of DeFi in 2026. You can read their full statement at https://blog.ethereum.org/2026/02/23/commitment-to-defi. We stand firmly behind this approach, which champions open standards, enduring security, and the integration of privacy as essential infrastructure. By prioritizing trustworthy risk terminology and making self-custody the default, they are setting the right course. We are completely aligned with this direction.
Tokenized strategies should offer freedom rather than limitations. You are empowered to construct these strategies using a wide array of assets, ranging from crypto and RWAs to stocks, bonds, and T-bills. This flexibility extends to every venue, covering DeFi, CeFi, and Trad, as well as any configuration you require, including cross-chain or hybrid setups.
Get started at: https://enzyme.finance/products/onyx?utm_source=x&utm_medium=organic&utm_content=post
Despite the current downward trend in the general market, our internal metrics are moving in a positive direction. We are pleased to report that Enzyme Myso has successfully surpassed $100M notional. Furthermore, Enzyme Onyx has attained $50M AUT since its launch in November. It appears that genuine momentum is something even the bear cannot bet against. 🐻
For fund platforms, providing tokenized funds to clients does not require sacrificing operational best practices or security standards. Enzyme Onyx allows you to deliver these services while keeping your protocols intact. Learn how this is achieved: https://enzyme.finance/actors/financial-service-providers?utm_source=x&utm_medium=organic&utm_content=post
Leave the strategy launch tactics of 2019 behind. Enzyme Onyx is the foundational technology stack designed to issue, structure, and administer tokenized funds and instruments. Check out the details below.
Transform your substantial token holdings into a revenue stream through covered calls. Enzyme Myso allows you to manage options completely on-chain, operating directly from your wallet without any brokers or intermediaries.
Learn more at https://enzyme.finance/products/myso?utm_source=x&utm_medium=organic&utm_content=post
Ambiguous reporting is the quickest route to eroding investor confidence. Determining precise valuations often becomes chaotic when a strategy relies on a mix of exchanges, independent wallets, and on-chain activities. By leveraging support from @Crypto1Token, asset managers can successfully bridge CeFi + DeFi data to ensure their figures are accurate and defensible.
Read the full story here: https://enzyme.finance/blog-posts/enzyme-and-1token-partnership?utm_source=x&utm_medium=organic&utm_content=post
It is easy to assume that purchasing a stock in TradFi is an immediate event, but have you ever looked into what happens behind the scenes? The truth is that the operation is not as instantaneous as your application portrays it to be. 1/🧵
Perpetuals are the most traded derivatives in crypto, yet most explanations miss the point.
Here is a new explainer by @letsgetonchain on how on-chain perpetuals actually function 👇 https://enzyme.finance/perpetuals-the-decentralized-derivative?utm_source=x&utm_medium=organic&utm_content=post
As a venture fund, you may be considering the deployment of tokenized funds. What you need is an infrastructure that enables you to collect fiat and/or crypto, and invest seamlessly across on-chain and off-chain projects. Bonus point: the ability to put capital to work while waiting for the right opportunities.